Matches in Wikidata for { <http://www.wikidata.org/entity/Q89023422> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q89023422 description "article scientifique publié en 2018" @default.
- Q89023422 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q89023422 description "im Juni 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89023422 description "scientific article published on 07 June 2018" @default.
- Q89023422 description "wetenschappelijk artikel" @default.
- Q89023422 description "наукова стаття, опублікована в червні 2018" @default.
- Q89023422 name "Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001" @default.
- Q89023422 name "Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001" @default.
- Q89023422 type Item @default.
- Q89023422 label "Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001" @default.
- Q89023422 label "Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001" @default.
- Q89023422 prefLabel "Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001" @default.
- Q89023422 prefLabel "Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001" @default.
- Q89023422 P1433 Q89023422-4828D217-95CD-43EA-AC30-391F95975DDA @default.
- Q89023422 P1476 Q89023422-C35AB6A7-5F2B-4261-A022-F13B2E3B3300 @default.
- Q89023422 P2093 Q89023422-0BC8A679-C560-4255-9D36-5C82E241B326 @default.
- Q89023422 P2093 Q89023422-156577C8-83C9-4EF0-BD28-3C951DF8A642 @default.
- Q89023422 P2093 Q89023422-1EEF42F0-5431-4D46-BD20-25AB2666997D @default.
- Q89023422 P2093 Q89023422-2BF855C9-7E31-4A4D-A7E1-335BC435FD87 @default.
- Q89023422 P2093 Q89023422-3CB7E001-D368-4EF3-8376-7D46D961E2C3 @default.
- Q89023422 P2093 Q89023422-4A956761-E15E-4C7F-8742-100314F9DF0D @default.
- Q89023422 P2093 Q89023422-6606FA4A-2449-4021-A3E8-61DBE3BC617B @default.
- Q89023422 P2093 Q89023422-6DF8103C-B8FD-42A9-BA81-ECA2272CCEF5 @default.
- Q89023422 P2093 Q89023422-72273178-8384-489E-B191-DC40C6453C7F @default.
- Q89023422 P2093 Q89023422-91A886E6-693C-4DED-82B5-585B2658CA02 @default.
- Q89023422 P2093 Q89023422-A1F59F55-82D9-4460-A68D-DD85B7045787 @default.
- Q89023422 P2093 Q89023422-A5CAF104-A5AE-4C28-9FF9-CB701E4C0E49 @default.
- Q89023422 P2093 Q89023422-AD5786F5-9709-414A-B6A5-5A4F807B2E9F @default.
- Q89023422 P2093 Q89023422-CD2743C1-6C54-463F-9D5C-DEF2AB9106C4 @default.
- Q89023422 P304 Q89023422-6564D397-BF78-4B61-B245-13AB0BCFECA9 @default.
- Q89023422 P31 Q89023422-DCE40089-C45A-42B9-8FA4-E3480AF3CAAF @default.
- Q89023422 P356 Q89023422-DCE4C39A-3F59-48EE-A1A0-A532BF66F596 @default.
- Q89023422 P433 Q89023422-B0BE58DE-B5A5-4444-8420-3EFB2C512E96 @default.
- Q89023422 P478 Q89023422-01A2E04E-B270-4CAB-BC3A-CBB1E0B6EEB4 @default.
- Q89023422 P50 Q89023422-1FFD0B22-692C-4F0A-8FE8-1A52D543FF29 @default.
- Q89023422 P50 Q89023422-A5C066BC-8253-4D18-ACDD-47B87CA7B9AA @default.
- Q89023422 P50 Q89023422-F32541B2-8FCE-4FA9-9AE5-DA79959BECED @default.
- Q89023422 P577 Q89023422-44DE0DD1-8D19-4B82-82EE-D4A8A0182EF7 @default.
- Q89023422 P698 Q89023422-924643B5-1024-4541-91AB-C5EF8C891381 @default.
- Q89023422 P921 Q89023422-09E058C2-3712-41BB-A050-D759760CF0CF @default.
- Q89023422 P921 Q89023422-10F4B887-B909-4704-878F-85BA07163A42 @default.
- Q89023422 P356 PBC.27256 @default.
- Q89023422 P698 29878490 @default.
- Q89023422 P1433 Q15754342 @default.
- Q89023422 P1476 "Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001" @default.
- Q89023422 P2093 "Barbara Asselin" @default.
- Q89023422 P2093 "Bruno Michon" @default.
- Q89023422 P2093 "Caroline Laverdiere" @default.
- Q89023422 P2093 "Jean-Marie Leclerc" @default.
- Q89023422 P2093 "Kara M Kelly" @default.
- Q89023422 P2093 "Kristen E Stevenson" @default.
- Q89023422 P2093 "Lewis B Silverman" @default.
- Q89023422 P2093 "Luis A Clavell" @default.
- Q89023422 P2093 "Maneka Puligandla" @default.
- Q89023422 P2093 "Maria Luisa Sulis" @default.
- Q89023422 P2093 "Marian H Harris" @default.
- Q89023422 P2093 "Marshall A Schorin" @default.
- Q89023422 P2093 "Peter D Cole" @default.
- Q89023422 P2093 "Stephen E Sallan" @default.
- Q89023422 P304 "e27256" @default.
- Q89023422 P31 Q13442814 @default.
- Q89023422 P356 "10.1002/PBC.27256" @default.
- Q89023422 P433 "10" @default.
- Q89023422 P478 "65" @default.
- Q89023422 P50 Q87319577 @default.
- Q89023422 P50 Q87969909 @default.
- Q89023422 P50 Q87969924 @default.
- Q89023422 P577 "2018-06-07T00:00:00Z" @default.
- Q89023422 P698 "29878490" @default.
- Q89023422 P921 Q18553852 @default.
- Q89023422 P921 Q47715 @default.